We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
ArQule (ARQL) in Focus: Stock Moves 15.6% Higher
ArQule, Inc. was a big mover last session, as the company saw its shares rise nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.65–$1.84 in the past one-month time frame, witnessed a sharp increase yesterday.
Although ArQule has seen no estimate revisions over the past two months, the Zacks Consensus Estimate for the current quarter has also revised downward over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
ArQule currently has a Zacks Rank #3 (Hold) while its Earnings ESPis negative.
ArQule, Inc. Price and Consensus
ArQule, Inc. Price and Consensus | ArQule, Inc. Quote
A better ranked stock worth considering in the Medical - Drugs industry is Enanta Pharmaceuticals, Inc. (ENTA - Free Report) which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ARQL going up? Or down? Predict to see what others think: Up or Down
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>